MR‐proADM as a Prognostic Marker in Patients With ST‐Segment–Elevation Myocardial Infarction—DANAMI‐3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy-Reference-Cited by-同舟云学术

MR‐proADM as a Prognostic Marker in Patients With ST‐Segment–Elevation Myocardial Infarction—DANAMI‐3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy

Published:2018-06-05 Issue:11 Volume:7 Page:
ISSN:2047-9980
Container-title:Journal of the American Heart Association
language:en
Short-container-title:JAHA

Author:

Falkentoft Alexander C.¹,Rørth Rasmus¹,Iversen Kasper²,Høfsten Dan E.¹,Kelbæk Henning¹,Holmvang Lene¹,Frydland Martin¹,Schoos Mikkel M.¹,Helqvist Steffen¹,Axelsson Anna¹,Clemmensen Peter³⁴,Jørgensen Erik¹,Saunamäki Kari¹,Tilsted Hans‐Henrik¹,Pedersen Frants¹,Torp‐Pedersen Christian⁵,Kofoed Klaus F.¹,Goetze Jens P.⁶,Engstrøm Thomas¹,Køber Lars¹

Affiliation:

1. Department of Cardiology, Rigshospitalet University of Copenhagen, Denmark

2. Department of Cardiology, Herlev Hospital University of Copenhagen, Herlev, Denmark

3. Division of Cardiology, Department of Medicine, Nykøbing Falster Hospital, Nykøbing Falster, Denmark

4. Department of General and Interventional Cardiology, University Heart Center Hamburg‐Eppendorf, Hamburg, Germany

5. Department of Health, Science and Technology, Aalborg University Hospital, Aalborg, Denmark

6. Department of Clinical Biochemistry, Rigshospitalet University of Copenhagen, Denmark

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference39 articles.

1. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST‐segment elevation;Ibanez B;Rev Esp Cardiol (Engl ed),2017

2. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients

3. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

4. Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries

5. Short- and Long-Term Cause of Death in Patients Treated With Primary PCI for STEMI

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Midregional‐proAdrenomedullin as a prognostic tool in sepsis and septic shock: A systematic review and meta‐analysis;European Journal of Clinical Investigation;2024-04-17

2. Research status and development trends of post-myocardial infarction heart failure: a bibliometric analysis from 2012 to 2022;2024-01-22

3. Recent advances in the diagnosis and management of acute myocardial infarction;Journal of the Chinese Medical Association;2023-10-06

4. Clinical Potential of Adrenomedullin Signaling in the Cardiovascular System;Circulation Research;2023-04-28

5. Emerging Biomarkers for Predicting Clinical Outcomes in Patients with Heart Disease;Life;2023-01-13